During the past decade, Synexus Clinical Research US, Inc.-Plano conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research US, Inc.-Plano" are "Genetic Obesity" (1 trials), "Helicobacter Pylori Infection" (1 trials), "Irritable Bowel Syndrome" (1 trials), "Obesity" (1 trials) and "Obesity Due to Melanocortin 4 Receptor Deficiency" (1 trials). Many other conditions were trialed in "Synexus Clinical Research US, Inc.-Plano" in a lesser frequency.

Most popular intervention types in "Synexus Clinical Research US, Inc.-Plano" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin" (1 trials), "Clarithromycin" (1 trials), "Lansoprazole" (1 trials), "Placebo" (1 trials) and "Setmelanotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Synexus Clinical Research US, Inc.-Plano" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus Clinical Research US, Inc.-Plano". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Synexus Clinical Research US, Inc.-Plano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Synexus Clinical Research US, Inc.-Plano, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".